betaxolol has been researched along with Diabetes Mellitus, Type 2 in 1 studies
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Janka, HU | 1 |
| Ziegler, AG | 1 |
| Larrat, V | 1 |
| Mehnert, H | 1 |
1 trial available for betaxolol and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
[The effect of the beta 1 selective beta blocker, betaxolol, on metabolism in type II diabetics].
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Betaxolol; Blood Pressure; Body Weight; Carboh | 1989 |